Variant report

Variant	esv3326630
Chromosome Location	chr9:116859356-116862304
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:120)
CpG islands
(count:488)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:120 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD1	chr9:116861095-116861396	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD2	chr9:116861454-116861668	HepG2	liver:	n/a	n/a
3	CTCF	chr9:116861100-116861250	RPTEC	kidney:	n/a	n/a
4	CTCF	chr9:116861489-116861497	MCF-7	breast:	n/a	n/a
5	CTCF	chr9:116860980-116861130	WERI-Rb-1	eye:	n/a	n/a
6	CTCF	chr9:116861020-116861170	HRE	kidney:	n/a	n/a
7	CTCF	chr9:116861004-116861118	MCF-7	breast:	n/a	n/a
8	CTCF	chr9:116860993-116861137	MCF-7	breast:	n/a	n/a
9	CTCF	chr9:116861000-116861150	SK-N-SH_RA	brain:	n/a	n/a
10	CTCF	chr9:116860340-116860490	SK-N-SH_RA	brain:	n/a	n/a
11	CTCF	chr9:116861020-116861170	WERI-Rb-1	eye:	n/a	n/a
12	CTCF	chr9:116861360-116861510	Caco-2	colon:	n/a	n/a
13	CTCF	chr9:116860980-116861130	SK-N-SH_RA	brain:	n/a	n/a
14	CTCF	chr9:116861498-116861515	MCF-7	breast:	n/a	n/a
15	CTCF	chr9:116861080-116861230	SAEC	small airway:	n/a	n/a
16	CTCF	chr9:116860980-116861130	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr9:116861020-116861170	Caco-2	colon:	n/a	n/a
18	CTCF	chr9:116861000-116861150	HUVEC	blood vessel:	n/a	n/a
19	CTCF	chr9:116860980-116861130	HA-sp	spinal cord:	n/a	n/a
20	CTCF	chr9:116861425-116861518	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr9:116861060-116861210	HepG2	liver:	n/a	n/a
22	CTCF	chr9:116860960-116861110	AG04449	skin:	n/a	n/a
23	CTCF	chr9:116861100-116861250	HRE	kidney:	n/a	n/a
24	CTCF	chr9:116861034-116861129	Pancreas_OC	pancreas:	n/a	n/a
25	CTCF	chr9:116860960-116861110	HMF	breast:	n/a	n/a
26	CTCF	chr9:116860980-116861130	MCF-7	breast:	n/a	n/a
27	CTCF	chr9:116860260-116860410	HRE	kidney:	n/a	chr9:116860320-116860333
28	CTCF	chr9:116860540-116860690	AG04449	skin:	n/a	n/a
29	CTCF	chr9:116861320-116861470	RPTEC	kidney:	n/a	n/a
30	CTCF	chr9:116861020-116861170	MCF-7	breast:	n/a	n/a
31	CTCF	chr9:116860964-116861150	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr9:116861000-116861150	HMEC	breast:	n/a	n/a
33	CTCF	chr9:116860920-116861070	BJ	skin:	n/a	n/a
34	CTCF	chr9:116860965-116861140	MCF-7	breast:	n/a	n/a
35	CTCF	chr9:116861000-116861150	K562	blood:	n/a	n/a
36	CTCF	chr9:116861019-116861084	NHEK	skin:	n/a	n/a
37	CTCF	chr9:116861020-116861170	HBMEC	blood vessel:	n/a	n/a
38	CTCFL	chr9:116860969-116861118	K562	blood:	n/a	n/a
39	E2F6	chr9:116860288-116860861	A549	lung:	n/a	chr9:116860320-116860330
40	EP300	chr9:116861425-116861878	HepG2	liver:	n/a	n/a
41	EP300	chr9:116859799-116860821	ECC-1	luminal epithelium:	n/a	n/a
42	FOXA1	chr9:116861391-116861924	HepG2	liver:	n/a	n/a
43	FOXA1	chr9:116861369-116861868	HepG2	liver:	n/a	n/a
44	FOXA1	chr9:116861322-116861871	HepG2	liver:	n/a	n/a
45	FOXA1	chr9:116861488-116861830	HepG2	liver:	n/a	n/a
46	FOXA2	chr9:116861491-116861814	HepG2	liver:	n/a	n/a
47	FOXA2	chr9:116861494-116861896	A549	lung:	n/a	n/a
48	FOXA2	chr9:116861287-116861938	A549	lung:	n/a	n/a
49	GATA2	chr9:116859731-116860162	SH-SY5Y	brain:	n/a	n/a
50	GATA3	chr9:116859734-116860229	MCF-7	breast:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:116861442-116861492	ProgFib	skin:	n/a
2	chr9:116861288-116861338	NHBE	bronchial:	n/a
3	chr9:116861532-116861582	AG09319	gingival:	n/a
4	chr9:116860650-116860700	HRCEpiC	kidney:	n/a
5	chr9:116861532-116861582	HIPEpiC	eye:	n/a
6	chr9:116861288-116861338	Jurkat	blood:	n/a
7	chr9:116860437-116860487	SAEC	small airway:	n/a
8	chr9:116861288-116861338	Caco-2	colon:	n/a
9	chr9:116859631-116859681	NH-A	brain:	n/a
10	chr9:116860437-116860487	AG04450	lung:	fetal
11	chr9:116860650-116860700	ECC-1	luminal epithelium:	n/a
12	chr9:116861532-116861582	HL-60	blood:	n/a
13	chr9:116860437-116860487	K562	blood:	n/a
14	chr9:116860500-116860550	HL-60	blood:	n/a
15	chr9:116861532-116861582	HRE	kidney:	n/a
16	chr9:116861288-116861338	MCF10A-Er-Src	breast:	n/a
17	chr9:116859631-116859681	AG09309	skin:	n/a
18	chr9:116859631-116859681	T-47D	breast:	n/a
19	chr9:116860500-116860550	HRE	kidney:	n/a
20	chr9:116860650-116860700	IMR90	lung:	fetal
21	chr9:116860650-116860700	GM12892	blood:	n/a
22	chr9:116860500-116860550	HEEpiC	esophagus:	n/a
23	chr9:116859631-116859681	PFSK-1	brain:	n/a
24	chr9:116860500-116860550	MCF-7	breast:	n/a
25	chr9:116860650-116860700	NB4	blood:	n/a
26	chr9:116861532-116861582	HCPEpiC	choroid plexus:	n/a
27	chr9:116861442-116861492	SK-N-SH_RA	brain:	n/a
28	chr9:116861288-116861338	GM06990	blood:	n/a
29	chr9:116860650-116860700	NT2-D1	testis:	n/a
30	chr9:116861288-116861338	NHDF-neo	bronchial:	n/a
31	chr9:116859631-116859681	U87	brain:	n/a
32	chr9:116861442-116861492	HNPCEpiC	eye:	n/a
33	chr9:116860500-116860550	ProgFib	skin:	n/a
34	chr9:116860500-116860550	T-47D	breast:	n/a
35	chr9:116861288-116861338	NT2-D1	testis:	n/a
36	chr9:116861404-116861454	GM19239	blood:	n/a
37	chr9:116860650-116860700	H1-hESC	embryonic stem cell:	embryo
38	chr9:116859631-116859681	ovcar-3	ovarian:	n/a
39	chr9:116860437-116860487	MCF10A-Er-Src	breast:	n/a
40	chr9:116860650-116860700	Jurkat	blood:	n/a
41	chr9:116860500-116860550	Hepatocyte	liver:	n/a
42	chr9:116861288-116861338	NH-A	brain:	n/a
43	chr9:116861288-116861338	SK-N-MC	brain:	n/a
44	chr9:116861288-116861338	ovcar-3	ovarian:	n/a
45	chr9:116861442-116861492	HCF	heart:	n/a
46	chr9:116860650-116860700	HCM	heart:	n/a
47	chr9:116861442-116861492	RPTEC	kidney:	n/a
48	chr9:116860650-116860700	HepG2	liver:	n/a
49	chr9:116860650-116860700	GM12891	blood:	n/a
50	chr9:116860437-116860487	SK-N-SH_RA	brain:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:116637031..116639708-chr9:116859646..116861440,2	MCF-7	breast:

No data

Variant related genes	Relation type
KIF12	TF binding region
KIF12	CpG island
ENSG00000157657	chromatin interactions

Extended variants
information (count: 126 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:126 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs577794396	chr9:116859371-116859372	Genic enhancers Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs139139312	chr9:116859378-116859379	Genic enhancers Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs373887979	chr9:116859382-116859383	Genic enhancers Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs190033902	chr9:116859400-116859401	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs574276140	chr9:116859409-116859410	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs202172983	chr9:116859425-116859426	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs141480412	chr9:116859428-116859429	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs542910408	chr9:116859446-116859447	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs559910539	chr9:116859453-116859454	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs149965120	chr9:116859466-116859467	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs545174966	chr9:116859528-116859529	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs565079469	chr9:116859530-116859531	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs374017140	chr9:116859543-116859544	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs376055324	chr9:116859554-116859555	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs550956687	chr9:116859572-116859573	Bivalent Enhancer Genic enhancers Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs76057724	chr9:116859629-116859630	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs34713490	chr9:116859659-116859660	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs550854537	chr9:116859669-116859670	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs202197309	chr9:116859698-116859699	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs376807210	chr9:116859724-116859725	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs370204060	chr9:116859726-116859727	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs372692049	chr9:116859735-116859736	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs201775940	chr9:116859738-116859739	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs114942807	chr9:116859748-116859749	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs3810929	chr9:116859769-116859770	Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs557971807	chr9:116859816-116859817	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs149103429	chr9:116859839-116859840	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs374263054	chr9:116859840-116859841	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs200284882	chr9:116859844-116859845	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs62556540	chr9:116859852-116859853	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs78769790	chr9:116859857-116859858	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs367617766	chr9:116859865-116859866	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs180786372	chr9:116859876-116859877	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs142274890	chr9:116859886-116859887	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs376740836	chr9:116859924-116859925	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs146774554	chr9:116859941-116859942	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs367963307	chr9:116859949-116859950	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs140619673	chr9:116859950-116859951	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs145677058	chr9:116859952-116859953	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs138294802	chr9:116859959-116859960	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs545244575	chr9:116859964-116859965	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs375497781	chr9:116859967-116859968	Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs369822984	chr9:116860012-116860013	Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs35070375	chr9:116860025-116860026	Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs565090738	chr9:116860068-116860069	Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs186232245	chr9:116860088-116860089	Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs544346639	chr9:116860112-116860113	Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs377501775	chr9:116860128-116860129	Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs561358871	chr9:116860222-116860223	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs188224677	chr9:116860225-116860226	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
small cell lung cancer	20016488	CNVD
Cardiac fibroma	18329553	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Lung cancer	19147751	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21509527	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Melanoma	17363583	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:357 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:116854800-116859600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr9:116855400-116859800	Weak transcription	Lung	lung
3	chr9:116855400-116859800	Weak transcription	Rectal Mucosa Donor 31	rectum
4	chr9:116856400-116859800	Weak transcription	Brain Inferior Temporal Lobe	brain
5	chr9:116857400-116859800	Weak transcription	Rectal Mucosa Donor 29	rectum
6	chr9:116858200-116859400	Weak transcription	Fetal Kidney	kidney
7	chr9:116858200-116859800	Weak transcription	Liver	Liver
8	chr9:116858400-116859400	Weak transcription	Duodenum Mucosa	Duodenum
9	chr9:116858400-116860000	Transcr. at gene 5' and 3'	Fetal Intestine Small	intestine
10	chr9:116858600-116859600	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
11	chr9:116858600-116859600	Genic enhancers	Pancreas	Pancrea
12	chr9:116858800-116859400	Weak transcription	Gastric	stomach
13	chr9:116858800-116860200	Enhancers	HepG2	liver
14	chr9:116858800-116862200	Active TSS	Pancreatic Islets	Pancreatic Islet
15	chr9:116859000-116859800	Transcr. at gene 5' and 3'	Fetal Intestine Large	intestine
16	chr9:116859200-116859600	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
17	chr9:116859200-116859800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr9:116859200-116859800	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr9:116859200-116860000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr9:116859200-116860200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
21	chr9:116859200-116860200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr9:116859200-116860200	Bivalent Enhancer	Brain Germinal Matrix	brain
23	chr9:116859200-116860600	Bivalent Enhancer	Fetal Muscle Leg	muscle
24	chr9:116859400-116860000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
25	chr9:116859400-116860000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr9:116859400-116860000	Enhancers	Colonic Mucosa	Colon
27	chr9:116859400-116860000	Enhancers	Gastric	stomach
28	chr9:116859400-116860400	Flanking Active TSS	Duodenum Mucosa	Duodenum
29	chr9:116859400-116860600	Bivalent Enhancer	Fetal Brain Male	brain
30	chr9:116859400-116861400	Active TSS	Fetal Kidney	kidney
31	chr9:116859400-116862200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
32	chr9:116859600-116859800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr9:116859600-116859800	Bivalent Enhancer	Fetal Stomach	stomach
34	chr9:116859600-116859800	Enhancers	A549	lung
35	chr9:116859600-116859800	Enhancers	HMEC	breast
36	chr9:116859600-116860200	Transcr. at gene 5' and 3'	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr9:116859600-116860200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr9:116859600-116860200	Flanking Active TSS	Pancreas	Pancrea
39	chr9:116859600-116860200	Enhancers	Stomach Mucosa	stomach
40	chr9:116859600-116860400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
41	chr9:116859600-116861800	Bivalent Enhancer	Placenta	Placenta
42	chr9:116859800-116860000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
43	chr9:116859800-116860000	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr9:116859800-116860000	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
45	chr9:116859800-116860000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr9:116859800-116860000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr9:116859800-116860000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr9:116859800-116860000	Bivalent Enhancer	Adipose Nuclei	Adipose
49	chr9:116859800-116860000	Bivalent Enhancer	Brain Angular Gyrus	brain
50	chr9:116859800-116860000	Bivalent Enhancer	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links